Regulators Draw a Line on Synthetic Health Data Sharing

Regulators in the UK, Singapore, and South Korea have clarified that synthetic health data is only treated as non-personal when residual disclosure risk is demonstrably low. The guidance puts the burden on data holders to show how datasets were generated, tested, and assessed before sharing.